These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
961 related articles for article (PubMed ID: 17143826)
1. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe. Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826 [TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL; J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045 [TBL] [Abstract][Full Text] [Related]
3. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China. Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969 [TBL] [Abstract][Full Text] [Related]
4. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. Lallemant M; Jourdain G; Le Coeur S; Kim S; Koetsawang S; Comeau AM; Phoolcharoen W; Essex M; McIntosh K; Vithayasai V N Engl J Med; 2000 Oct; 343(14):982-91. PubMed ID: 11018164 [TBL] [Abstract][Full Text] [Related]
5. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. Shapiro RL; Thior I; Gilbert PB; Lockman S; Wester C; Smeaton LM; Stevens L; Heymann SJ; Ndung'u T; Gaseitsiwe S; Novitsky V; Makhema J; Lagakos S; Essex M AIDS; 2006 Jun; 20(9):1281-8. PubMed ID: 16816557 [TBL] [Abstract][Full Text] [Related]
6. Single-dose Nevirapine during pregnancy. Sax PE AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708 [TBL] [Abstract][Full Text] [Related]
7. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV. Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656 [TBL] [Abstract][Full Text] [Related]
8. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654 [TBL] [Abstract][Full Text] [Related]
9. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants. Prasitwattanaseree S; Lallemant M; Costagliola D; Jourdain G; Mary JY Antivir Ther; 2004 Apr; 9(2):179-85. PubMed ID: 15134179 [TBL] [Abstract][Full Text] [Related]
10. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1. Eshleman SH; Hoover DR; Hudelson SE; Chen S; Fiscus SA; Piwowar-Manning E; Jackson JB; Kumwenda NI; Taha TE J Infect Dis; 2006 Feb; 193(4):479-81. PubMed ID: 16425125 [TBL] [Abstract][Full Text] [Related]
12. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission. Jackson JB; Parsons T; Musoke P; Nakabiito C; Donnell D; Fleming T; Mirochnick M; Mofenson L; Fowler MG; Mmiro F; Guay L AIDS; 2006 Jan; 20(2):217-22. PubMed ID: 16511414 [TBL] [Abstract][Full Text] [Related]
13. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822 [TBL] [Abstract][Full Text] [Related]
15. A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe. Thistle P; Gottesman M; Pilon R; Glazier RH; Arbess G; Phillips E; Wald RL; Chitsike I; Simor A; Chipato T; Silverman M Cent Afr J Med; 2004; 50(9-10):79-84. PubMed ID: 16411341 [TBL] [Abstract][Full Text] [Related]
16. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. Lallemant M; Jourdain G; Le Coeur S; Mary JY; Ngo-Giang-Huong N; Koetsawang S; Kanshana S; McIntosh K; Thaineua V; N Engl J Med; 2004 Jul; 351(3):217-28. PubMed ID: 15247338 [TBL] [Abstract][Full Text] [Related]
17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758 [TBL] [Abstract][Full Text] [Related]
18. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M; JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785 [TBL] [Abstract][Full Text] [Related]
19. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. Martinson NA; Morris L; Johnson J; Gray GE; Pillay V; Ledwaba J; Dhlamini P; Cohen S; Puren A; Steyn J; Heneine W; McIntyre JA AIDS; 2009 Apr; 23(7):809-16. PubMed ID: 19287298 [TBL] [Abstract][Full Text] [Related]
20. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]